These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20494296)

  • 41. An assessment of surgical thromboprophylaxis in a tertiary care center.
    Robinson-Cohen C; Pilon D; Dubois MF; Tagalakis V
    Clin Appl Thromb Hemost; 2011; 17(6):E39-45. PubMed ID: 20829273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Venous thromboembolism risk and thromboprophylaxis among hospitalized patients: data from the Turkish arm of the ENDORSE study.
    Ongen G; Yılmaz A; Cirak AK; Ersoy CY; Erden F; Altıntaş F; Yıldırım C; Güven H; Demir A; Kaynar L; Bastacı N; Demirtaş N
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):539-45. PubMed ID: 20829272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Length of Thromboprophylaxis in Patients Operated on for a High-Grade Glioma: A Retrospective Study.
    Senders JT; Snijders TJ; van Essen M; van Bentum GM; Seute T; de Vos FY; Smith TR; Robe PA; Broekman MLD
    World Neurosurg; 2018 Jul; 115():e723-e730. PubMed ID: 29715571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of thromboprophylaxis in hospitalised medical patients. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE).
    Spirk D; Nendaz M; Aujesky D; Hayoz D; Beer JH; Husmann M; Frauchiger B; Korte W; Wuillemin WA; Righini M; Bounameaux H; Kucher N
    Thromb Haemost; 2015 May; 113(5):1127-34. PubMed ID: 25608607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Updated clinical models for VTE prediction in hospitalized medical patients.
    Gerotziafas GT; Papageorgiou L; Salta S; Nikolopoulou K; Elalamy I
    Thromb Res; 2018 Apr; 164 Suppl 1():S62-S69. PubMed ID: 29703486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The TOronto ThromboProphylaxis Patient Safety Initiative (TOPPS): A cluster randomised trial.
    Diamantouros A; Kiss A; Papastavros T; U D; Zwarenstein M; Geerts WH
    Res Social Adm Pharm; 2017; 13(5):997-1003. PubMed ID: 28583301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patients.
    Amin AN; Varker H; Princic N; Lin J; Thompson S; Johnston S
    J Hosp Med; 2012 Mar; 7(3):231-8. PubMed ID: 22190427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study.
    Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Turpie AG; Wildgoose P; Yusen RD
    J Thromb Thrombolysis; 2006 Aug; 22(1):31-8. PubMed ID: 16786230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients. A retrospective multicenter study.
    Nieto JA; Cámara T; Camacho I;
    Eur J Intern Med; 2014 Oct; 25(8):717-23. PubMed ID: 25091470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is extended thromboprophylaxis necessary in elective colorectal cancer surgery?
    Chandra R; Melino G; Thomas M; Lawrence MJ; Hunter RA; Moore J
    ANZ J Surg; 2013 Dec; 83(12):968-72. PubMed ID: 23802729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thromboprophylaxis in surgical and medical patients.
    Bozzato S; Galli L; Ageno W
    Semin Respir Crit Care Med; 2012 Apr; 33(2):163-75. PubMed ID: 22648489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thromboprophylaxis for hospitalized medical patients: a multicenter qualitative study.
    Cook D; Tkaczyk A; Lutz K; McMullin J; Haynes RB; Douketis J
    J Hosp Med; 2009 May; 4(5):269-75. PubMed ID: 19504488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unmet definitions in thromboprophylaxis for hospitalized medical patients: An appraisal for the need of recommendation.
    Ávila Ferreira B; de Bastos M; Rezende SM
    Res Pract Thromb Haemost; 2022 Oct; 6(7):e12827. PubMed ID: 36330328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ACP Journal Club. Review: interventions to increase thromboprophylaxis do not benefit inpatients at risk for VTE.
    Baumann Kreuziger LM
    Ann Intern Med; 2013 Nov; 159(10):JC10, JC11. PubMed ID: 24247688
    [No Abstract]   [Full Text] [Related]  

  • 55. Deconditioning in Hospitalized Patients with Cancer.
    Gilson S
    Semin Oncol Nurs; 2024 Aug; 40(4):151676. PubMed ID: 38945732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thromboprophylaxis after Hospitalization for Medical Illness.
    Spyropoulos AC; Barnathan ES; Raskob GE;
    N Engl J Med; 2018 Dec; 379(23):2280. PubMed ID: 30575454
    [No Abstract]   [Full Text] [Related]  

  • 57. Measures of risk and their relationship to the relative size of a high-risk group: application to medical thromboprophylaxis.
    Millar JA
    Clin Epidemiol; 2012; 4():275-81. PubMed ID: 23152704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tackling immobility in hospitalized seniors.
    Stall N
    CMAJ; 2012 Oct; 184(15):1666-7. PubMed ID: 22988157
    [No Abstract]   [Full Text] [Related]  

  • 59. Limitations of venous thromboembolism risk assessment models in medical patients: Response to "Unmet definitions in thromboprophylaxis for hospitalized medical patients: An appraisal for the need of recommendation".
    Er C; Cohen AT
    Res Pract Thromb Haemost; 2023 Jan; 7(1):100027. PubMed ID: 36970746
    [No Abstract]   [Full Text] [Related]  

  • 60. The Epidemic of Immobility in Hospitalised Patients: How to Get Your Patient Up and Moving.
    O'Neill DE; Heckman GA; Graham MM
    Can J Cardiol; 2024 Aug; 40(8):1483-1486. PubMed ID: 38522622
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.